Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Cancer. 2021 Aug 3;127(21):3957–3966. doi: 10.1002/cncr.33679

Table 5:

How should germline risk assessment be performed?*

Consensus question Yes No

Can physicians (urologists/oncologist) with expertise in hereditary kidney cancer syndromes offerpre-test counseling in patients suspected of having hereditary kidney cancer? 92% 8%

Is a standardized video covering essential elements of counseling sufficient for pre-test counseling in individuals suspected of having hereditary kidney cancer? 59% 41%

Should germline testing in patients who did not have any pre-test counseling be performed? 0% 100%

If an individualizedpre-test counseling was not performed, but germline testing is pursed, testing should:
  a) include a comprehensive cancer gene panel to avoid testing too narrowly 8%
  b) include a kidney specific gene panel only to keep focused 92%

Is a telehealth/telegenetics visit with a licensed counselor sufficient for evaluation of individuals suspected of having hereditary kidney cancer? 93% 7%

Should individuals with variants of unknown significance (VUS) in genes that could explain a hereditary kidney cancer phenotype be treated as affected until more information if obtained? 56% 44%
*

Statements in bold represent those with reached consensus